The staurosporine producing strain streptomyces longisporoflavus produces metabolites related to K-252a. Proposal for biosynthetic intermediates of K-252a

Journal of Antibiotics

Volumn 49, Issue 10, 1996, Pages 1060-1062

  Cai, Yang ^a   Fredenhagen, Andreas ^a   Hug, Paul ^b   Peter, Heinrich H ^a  

^a Pharmaceutical Research ^*  (Switzerland)

^b CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; K 252A; PROTEIN KINASE; PROTEIN KINASE C; STAUROSPORINE;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STREPTOMYCES;

EID: 0029842007     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.1060     Document Type: Article

References (15)

1. ŌMURA, S.; Y. IWAI, A. HIRANO, A. NAKAGAWA, J. AWAYA, H. TSUCHIYA, Y. TAKAHASHI & R. MASUMA: A new alkaloid AM-2282 of Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J. Antibiotics 30: 275-282, 1977
2. TAMAOKI, T.; H. NOMOTO, I. TAKAHASHI, Y. KATO, M. MORIMOTO& F. TOMITA: Staurosporine, a potent inhibitor of phospholipid/calcium dependent protein kinase. Biochem. Biophys. Res. Commun. 135: 397-402, 1986
3. TANIDA, S.; M. TAKIZAWA, T. TAKAHASHI, S. TSUBOTANI & S. HARADA: TAN-999 and TAN-1030A, new indolo-carbazole alkaloids with macrophage-activating properties. J. Antibiotics 42: 1619-1630, 1989
4. TAKAHASHI, I.; K. ASANO, I. KAWAMOTO, T. TAMAOKI & H. NAKANO: UCN-01 and UCN-02, new selective inhibitors of protein kinase C. I. Screening, producing organism and fermentation. J. Antibiotics 42: 564-570, 1989
5. OSADA, H.; H. TAKAHASHI, K. TSUNODA, H. KUSAKABE & K. ISONO: A new inhibitor of protein kinase C, RK-286C (4′-demethylamino-4′-hydroxystaurosporine). I. Screening, taxonomy, fermentation and biological activity. J. Antibiotics 43: 163-167, 1990
6. CAI, Y.; A. FREDENHAGEN, P. HUG & H. H. PETER: A nitro analogue of staurosporine and other minor metabolites produced by a Streptomyces longisporoflavus strain. J. Antibiotics 48: 143-148, 1995
7. KASE, H.; K. IWAHASHI & Y. MATSUDA: K-252a, a potent inhibitor of protein kinase C from microbial origin. J. Antibiotics 39: 1059-1065, 1986
8. YASUZAWA, T.; T. IIDA, M. YOSHIDA, N. HIRAYAMA, M. TAKAHASHI, K. SHIRAHATA & H. SANO: The structures of the novel protein kinase C inhibitors K-252a, b, c and d. J. Antibiotics 39: 1072-1078, 1986
9. KNUSEL, B.; D. R. KAPLAN, J. W. WINSLOW, A. ROSENTHAL, L. E. BURTON, K. D. BECK, S. RABIN, K. NIKOLICS & F. HEFTI: K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3. J. Neurochem. 59: 715-22, 1992
10. CAI, Y.; A. FREDENHAGEN, P. HUG, T. MEYER & H. H. PETER: Further minor metabolites of staurosporine produced by a Streptomyces longisporoflavus strain. J. Antibiotics 49: 519-527, 1996
11. FUNATO, N.; H. TAKAYANAGI, Y. KONDO, Y. TODA, Y. HARIGAYA, Y. IWAI & S. ŌMURA: Absolute configuration of staurosporine by X-ray analysis. Tetrahedron Lett. 1994: 1251-1254, 1994
12. KIRKUP, M. P. (Schering Corp.): 4′-(N-substituted) staurosporine N-oxide derivatives. PCT Int. Appl. WO 9307153 A1 930415
13. FREDENHAGEN, A. & H. H. PETER: New stereoselective Beckmann-type rearrangement leading to ring contraction. Tetrahedron 52: 1235-1238, 1996
14. MEYER, T.; U. REGENASS, D. FABBRO, E. ALTERI, J. RÖSEL, M. MÜLLER, G. CARAVATTI & A. MATTER: A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int. J. Cancer 43: 851-856, 1989
15. MEKSURIYEN, D. & G. A. CORDELL: Biosynthesis of staurosporine, 2. Incorporation of tryptophan. J. Nat. Prod. 51: 893-899, 1988